ClinicalTrials.gg
Sign In

Femoracetabular Impingement clinical trials

The registry lists 116 studies for Femoracetabular Impingement across more than 10 countries. 37 are recruiting or about to start. 101 of them are mainly about Femoracetabular Impingement (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Femoracetabular Impingement studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
47
Recruiting
19
Not yet recruiting
14
Status unknown
10
Active, not recruiting
9
Withdrawn
9

Phase

Phase 4
9
Phase 1
2
Phase 2
2
Phase 3
2
Early Phase 1
1

Where

United States
37
Canada
15
China
11
Denmark
9
Belgium
6
France
5

Who runs them

Peking University Third Hospital (9) · Ottawa Hospital Research Institute (7) · Universitaire Ziekenhuizen KU Leuven (5) · Istituto Ortopedico Rizzoli (4) · Washington University School of Medicine (4) · American Hip Institute (4) · University of Colorado, Denver (3) · Cambridge University Hospitals NHS Foundation Trust (3)

What is being tested here

Drugs under test in Femoracetabular Impingement studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Nandrolone Decanoate101
Nandrolone101
Ketorolac101
Omeprazole101
Bupivacaine002
Clonidine002
Ropivacaine002
Platelet rich plasma002
Fisetin001
Naproxen001

Drug classes tested here Local anesthetics 4

Coming up

1phase 3 study under way
11studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 19 Femoracetabular Impingement studies recruiting now, 6 (32%) set no upper age limit and 11 (58%) stop at 75 or younger. 3 (16%) take children under 18. 0 (0%) are for women only and 1 (5%) for men only; 6 (32%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
100 (0%)0 (0%)
1817 (89%)17 (89%)
3017 (89%)18 (95%)
4017 (89%)17 (89%)
5015 (79%)15 (79%)
659 (47%)9 (47%)
759 (47%)9 (47%)
857 (37%)7 (37%)

Across all 116 studies, recruiting or not: 70% stop at 75 or younger and 66% at 65; 26% take children; 0% are for women only and 3% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Femoracetabular Impingement studies take

Of 42 interventional studies with no phase under Femoracetabular Impingement, half reached primary completion within 41 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase41 mo28–79 · 42 studies—41 mo28–79 · 41 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 116. Browse all 116 → or search them.